Pharmaceuticals for the treatment of degenerative muscular diseases and disorders; pharmaceuticals for the treatment of diseases and disorders of the central nervous system, neuromuscular diseases and disorders, pulmonary diseases and disorders, metabolic diseases and disorders, fibrotic diseases and disorders, mitochondrial diseases and disorders, inflammatory diseases and disorders and diseases and disorders of the bone and cartilage